News
BSG guidance recommends switching to biosimilar infliximab
2016-10-14 The British Society of Gastroenterology (BSG) released new guidance in February 2016 recommending that stable patients be switched to biosimilar infliximab (CT-P13). Biosimilar infliximab, Remisima/Inflectra… Read More »
Consumer choice between generic and brand-name medicines in a small generics market
2016-10-12 Background Generics offer an opportunity to governments to contain pharmaceutical expenditures, as they are generally 10‒80% lower in price than the originator brand-name medicines. Belgium… Read More »
Differences between biosimilars and reference products
2016-10-10 A review of glycosylated biosimilars approved in the European Union (EU) and Japan has highlighted structural variances between biosimilars and their reference products [1]. Biosimilars… Read More »
Impact of generics on European budgets
2016-10-07 A report by the Germany-based Institute for Healthcare and Social Research (IGES) released on 16 November 2015 found that generics could contribute to reducing healthcare… Read More »
Pharmacists’ attitudes towards domestic generics in Afghanistan
2016-10-05 The aim of the study by Hassali et al. was to survey community pharmacists regarding their attitudes about the quality and price of locally manufactured… Read More »
Prescribing similar biotherapeutic products in Latin America
2016-10-03 Prescribing practices vary across different countries in Latin America and reveal gaps in understanding and in the use of distinguishable names for biologicals [1]. A… Read More »
Paediatric use of low-cost generic programs in the US
2016-09-30 Low-cost generic drug programs (LCGPs) in the US increase the affordability of prescription medication that can treat many common paediatric conditions. LCGPs are a loss-leader… Read More »
Generics market share in Europe
2016-09-28 Generics make a major contribution to the European drug supply, according to a report by the by Germany-based Institute for Healthcare and Social Research (IGES).… Read More »
Physicians’ and pharmacists’ perspectives on generics use
2016-09-26 The review study of Toverud et al. shows that both physicians and pharmacists have acknowledged strategies for generics use as an attempt to curtail increasing… Read More »
Barriers to biologicals competition
2016-09-23 As finding breakthrough small-molecule drugs becomes more difficult, drug companies are increasingly turning to ‘large molecule’ biologicals. Although biologicals represent many of the most promising… Read More »
